Clinical Trials Directory

Trials / Completed

CompletedNCT00251602

Analysis of Atropine and Propranolol Induced Changes

Wavelet Transform and Pharmacodynamic Analysis of Atropine and Propranolol Induced Changes in Human Heart Rate Variability

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
National Institute on Aging (NIA) · NIH
Sex
All
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to learn the effects of genetic make up on response to the drugs atropine and propranolol, to examine how changes in heart rate and blood pressure can be measured, and to test a new statistical analysis method.

Detailed description

Healthy volunteers will be recruited and screened for eligibility. Participants will be placed into three possible groups based on genetic information obtained during screening. Rolling admissions will continue until at least 10 participants have been recruited for each genetic group. Participants will be randomly assigned to receive either the control (propranolol and saline) or combined drug (propranolol and atropine) treatment in a non-blinded fashion. The participant will return over one week later to receive the alternate treatment. Continuous heart rate/blood pressure data will be recorded until the end of the study period. Respiratory rate will be maintained at a fixed rate. Participants will undergo an orthostasis task, receive the drug or control infusions, and blood samples will then be obtained to determine drug concentrations at specific time intervals. Several relatively new mathematical techniques will be applied to the data.

Conditions

Interventions

TypeNameDescription
DRUGAtropineOne-time 10 mcg/kg infusion over 30 minutes, followed by a 10 mcg/kg bolus
DRUGPropranololOne-time 0.8mg/kg/hr infusion (maximum dose not to exceed 20mg) over 20 minutes, followed by either atropine or normal saline
DRUGNormal SalineOne-time 0.25 ml/min infusion over 30 minutes

Timeline

Start date
2003-03-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2005-11-10
Last updated
2012-08-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00251602. Inclusion in this directory is not an endorsement.